News | Ultrasound Imaging | September 08, 2023

Super resolution contrast-enhanced ultrasound (CEUS) application available on EPIQ Elite ultrasound system 

The introduction of a new contrast-enhanced ultrasound (CEUS) application on Philips EPIQ Elite helps enhance diagnostic confidence for cancer patients.

September 8, 2023 — When diagnosing and treating cancer patients, the dynamics of blood flow to and from a suspected lesion can provide clinicians with valuable diagnostic information. For example, blood flow through a liver tumor can offer insights into how likely it is that the cancer could spread. The current standard of care for assessing lesion blood flow requires the intravenous injection of an iodinated contrast media that is not well tolerated by some patients. In these instances, contrast-enhanced ultrasound (CEUS) is rapidly becoming a viable alternative as an increasingly important tool for lesion characterization.  

Instead of using an iodinated contrast media, CEUS leverages micro-bubble contrast media, based on an inert gas that is excreted via the patient’s breathing. With the introduction of Philips Microvascular Imaging Super Resolution Contrast-Enhanced Ultrasound (CEUS) on Philips Ultrasound System – EPIQ Elite – CEUS imaging now delivers up to 200% better spatial resolution than previous offerings.  

“Philips’ microvascular imaging allows us to visualize the pattern of contrast media flow into a lesion, and also shows how it changes over time, which gives us greater diagnostic confidence in assessing indeterminate lesions,” said Professor Dirk-André Clevert, Professor of Radiology at Ludwig-Maximilians-Universität (LMU), Munich, Germany. “Sharing our knowledge about how to use this latest technology and interpret the results has been greatly enhanced by Philips’ latest Collaboration Live software [1], which allows us to remotely train external sonographers and guide them through procedures.”   

Delivering exceptional detail and enhanced patient safety 

Like other CEUS modalities, super resolution microvascular imaging (MVI) does not expose patients to ionizing radiation and is generally more cost-effective and more accessible. Compared to iodinated contrast media, adverse reaction rates to the micro-bubble contrast media used for CEUS are also much lower.  

EPIQ Elite is a premium ultrasound system that combines the latest advances in transducer innovation and enhanced performance to help improve clinical confidence and deliver personalized care for patients. Featuring a wide range of multiple diagnostic applications and tools tailored to meet the needs of specific medical specialties, EPIQ Elite offers exceptional levels of clinical performance combined with the workflow efficiency needed to meet the challenges of today’s demanding practices. 

Philips Ultrasound System – EPIQ Elite – with Microvascular Imaging Super Resolution CEUS is being showcased by Philips at the International Bubble Conference (September 7-8, 2023, Chicago, USA), where Professor Clevert will give a presentation titled ‘New Super Resolution MVI and Time of Arrival Imaging (TOA) in the Characterization of Liver Lesions.’ Visit Philips EPIQ Elitefor more information on Philips premium ultrasound.  

For more information: www.philips.com 

Reference: 

[1] Contract required. Collaboration Live is intended for remote diagnostic use on release 9 or higher.


Related Content

News | Radiopharmaceuticals and Tracers

May 8, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of ...

Time May 08, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Feature | Digital Radiography (DR) | By Melinda Taschetta-Millane

Digital radiography (DR) continues to advance at a rapid pace with today’s technological innovations and evolving ...

Time May 06, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
arrow
Feature | Radiation Dose Management | By Christine Book

Advances in the growing radiation dose management market are continually helping those who administer treatment to focus ...

Time May 03, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
News | Breast Imaging

April 30, 2024 — Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports ...

Time April 30, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
Subscribe Now